Tunable Molecular Weight DP Icon
Enzyme optimization allows for precise control over the DP, tailoring Levan for prebiotic or material applications.
Levan, a polyfructan, is an exopolysaccharide with applications as a Prebiotics/Film Formers in food, cosmetics, and pharmaceuticals due to its water-solubility and unique structure. The current production methods face a major hurdle: Low yield and high cost of purification from traditional Bacillus fermentation. This limits its cost-effectiveness and scalability for industrial use.
CD Biosynsis offers a two-pronged strategy focused on enzyme and feedstock efficiency: Enzyme Engineering: Overexpress the Levansucrase enzyme in E. coli or yeast and optimize the enzyme reaction to control the degree of polymerization DP. This ensures a high-quality product with tailored properties. Additionally, we implement Feedstock Utilization: Engineer the host to utilize cheap feedstocks like sucrose. By optimizing the use of economical carbon sources, we significantly reduce the overall production cost.
Get a QuoteThe industrial production of Levan faces these primary constraints:
A cost-effective solution must improve Levansucrase activity and enable cheaper, high-titer production.
CD Biosynsis utilizes enzyme engineering and metabolic optimization for enhanced Levan production:
High-Yield Enzyme Expression
We overexpress the Levansucrase enzyme in robust, high-density fermentation hosts e.g. E. coli or yeast for high enzyme titer and purity.
Precise DP Control
We optimize enzyme reaction conditions e.g. sucrose concentration and use enzyme mutants to precisely tune the Degree of Polymerization DP of the Levan product.
Cost-Effective Feedstock Use
We engineer the host Bacillus or E. coli to efficiently utilize cheap sucrose sources e.g. molasses and co-utilize other sugars, reducing raw material costs.
Simplified Downstream Processing
By using cell-free or extracellular enzyme systems in a clean host, we significantly simplify the purification steps required for high-purity Levan.
This biological and process optimization strategy ensures a high-quality, cost-competitive Levan supply.
Our Levan engineering service is dedicated to pursuing the following production goals:
Tunable Molecular Weight DP Icon
Enzyme optimization allows for precise control over the DP, tailoring Levan for prebiotic or material applications.
High Enzyme Activity and Stability Icon
Overexpression in robust hosts provides large amounts of highly active Levansucrase, improving reaction kinetics.
Lower Feedstock Cost Icon
Host engineering enables the efficient use of cheap sucrose-based byproducts e.g. molasses, cutting production expenses.
Simplified Purification Icon
Cell-free or extracellular production dramatically reduces the steps and cost associated with downstream processing.
High Product Purity Icon
The in-vitro or enzyme reaction approach minimizes impurities related to biomass and other byproducts.
We deliver a scalable, high-purity, and functional Levan product for demanding industrial markets.
Our Levan engineering service follows a rigorous, multi-stage research workflow:
Technical communication is maintained throughout the process, focusing on timely feedback regarding yield and product quality attributes.
Explore the potential for a cost-efficient, molecularly-defined Levan supply. CD Biosynsis provides customized strain and process engineering solutions:
Why is controlling DP Degree of Polymerization important for Levan?
The DP of Levan dictates its functional properties. Low-DP Levan is often soluble and acts as a prebiotic or humectant. High-DP Levan has higher viscosity and film-forming capabilities, suitable for material applications. Precise control over DP allows for custom synthesis for a specific market need.
How does the Levansucrase enzyme work?
Levansucrase is a transfructosylase. It cleaves sucrose into glucose and fructose, then transfers the fructosyl unit to a growing Levan chain or to water hydrolysis. By adjusting sucrose concentration and water activity e.g. adding ethanol or other cosolvents, we can steer the reaction towards polymerization or hydrolysis to control DP.
Why switch from Bacillus to E. coli or yeast for Levansucrase production?
E. coli and yeast are highly efficient microbial factories for recombinant protein production. Switching allows for faster growth, higher enzyme titer, and easier downstream purification of the enzyme itself compared to the native Bacillus host, which produces many other polysaccharides and impurities.
How do you utilize cheap feedstocks like molasses?
Molasses is a byproduct of sugar refining that contains high levels of sucrose. By ensuring the host strain has an optimized sucrose uptake and metabolism system, we can bypass the need for expensive, purified sucrose, thereby significantly reducing the raw material cost of Levan production.
What is the estimated project timeline?
A comprehensive project involving enzyme engineering, DP tuning, and feedstock optimization typically requires 26-34 weeks for final enzyme system delivery and validated production protocol.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.